1 – 10 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
DAPAgliflozin for renal protection in heart transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
- Contribution to journal › Article
- 2025
-
Mark
All-cause mortality and death by aortic dissection in women with Turner syndrome : A national clinical cohort study
- Contribution to journal › Article
-
Mark
Rationale and design of a registry-based randomized controlled study of personalized biomarker-based risk score-guided stroke prevention treatment in atrial fibrillation
- Contribution to journal › Article
-
Mark
HELicobacter Pylori screening to prevent gastrointestinal bleeding in patients with acute Myocardial Infarction (HELP-MI SWEDEHEART) - Design and rationale of a cluster randomized, crossover, registry-based clinical trial
Hofmann, Robin ; James, Stefan ; Sundqvist, Martin O. ; Wärme, Jonatan ; Fröbert, Ole ; Angerås, Oskar ; Hellström, Per M. ; Hambraeus, Kristina ; Alfredsson, Joakim and Erlinge, David LU
, et al.
(2025)
In American Heart Journal
286.
p.66-74
- Contribution to journal › Article
-
Mark
Data quality assessment in the SWEDEHEART registry : Insights from serial audits on completeness and accuracy
Leosdottir, Margret LU ; Dahlbom, Lars ; Bäck, Maria ; Wallentin, Lars ; Alfredsson, Joakim ; Erlinge, David LU
; Jernberg, Tomas
and Hagström, Emil
(2025)
In American Heart Journal
288.
p.149-158
- Contribution to journal › Article
- 2024
-
Mark
Rationale and design of INFINITY-SWEDEHEART : A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
Erlinge, David LU
; Andersson, Jonas
; Fröbert, Ole
; Törnerud, Mattias
; Böhm, Felix
; Held, Claes
; Elek, Candace
; Sirhan, Motasim
; Oldgren, Jonas
and James, Stefan
(2024)
In American Heart Journal
277.
p.1-10
- Contribution to journal › Article
- 2023
-
Mark
Rationale and design of BROKEN-SWEDEHEART : a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome
Omerovic, Elmir ; James, Stefan ; Erlinge, David LU
; Hagström, Henrik
; Venetsanos, Dimitrios
; Henareh, Loghman
; Ekenbäck, Christina
; Alfredsson, Joakim
; Hambreus, Kristina
and Redfors, Björn
(2023)
In American Heart Journal
257.
p.33-40
- Contribution to journal › Article
-
Mark
Rationale and design of the DAPA-MI trial : Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
James, Stefan ; Erlinge, David LU
; Storey, Robert F.
; McGuire, Darren K.
; de Belder, Mark
; Björkgren, Ida
; Johansson, Peter A.
; Langkilde, Anna Maria
; Ridderstråle, Wilhelm
and Parvaresh Rizi, Ehsan
, et al.
(2023)
In American Heart Journal
266.
p.188-197
- Contribution to journal › Article
-
Mark
A cross-stakeholder approach to improving out-of-hospital cardiac arrest survival
- Contribution to journal › Article
-
Mark
Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial) : Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial
Malm, Carl Johan ; Alfredsson, Joakim ; Erlinge, David LU
; Gudbjartsson, Tomas
; Gunn, Jarmo
; James, Stefan
; Møller, Christian H.
; Nielsen, Susanne J.
; Sartipy, Ulrik
and Tønnessen, Theis
, et al.
(2023)
In American Heart Journal
259.
p.1-8
- Contribution to journal › Article